Our Story

Viatris in Australia

With approximately 800 employees, our Australian business is a prime example of our proven scientific, manufacturing and distribution expertise with leading regulatory, medical and commercial capabilities which bring quality medicines to patients when and where they need them.

Our Mission

At Viatris, we see healthcare not as it is, but as it should be. We act courageously and are uniquely positioned to be a source of stability in a world of evolving healthcare needs.

Viatris empowers people worldwide to live healthier at every stage of life.

We do so via:

Access

Providing high quality, trusted medicines, regardless of geography or circumstance

Leadership

Advancing sustainable operations and innovative solutions to improve patient health

Partnership

Leveraging our collective expertise to connect people to products and services

Advancing patient education and care is a priority for Viatris in Australia. We support education initiatives in therapy areas such as allergy and asthma working with patient group Allergy and Anaphylaxis Australia.

We work to ensure a safe, productive and positive work environment that fosters inclusion, integrity and mutual respect for all.

We work with global and local partners on a variety of philanthropic efforts, including supporting education, community health programs and better access to treatment.

We are committed to environmentally responsible conduct and have policies and procedures to systematically minimise our environmental footprint.

On a global public health level, we advocate for policies that advance knowledge and education, reduce barriers to treatment access to achieve better health for patients and unlock value for health systems.

How we help patients

Our global portfolio has approximately 1,400 molecules across a broad range of therapeutic areas spanning non-communicable and infectious diseases, including brand-name products, generics and OTC medicines.

Globally we are a provider of biosimilars, an industry we helped found, with more than 150 marketing approvals for biosimilars in more than 85 countries.

Our diverse portfolio delivers trusted, quality medicines that treat nine out of 10 of the World Health Organization’s (WHO) leading causes of death and more than 200 of our medicines are on the WHO Essential Medicines List.

We are a leading supplier of medicines to the HIV/AIDS community around the world, with a legacy of providing access to high quality and affordable antiretrovirals in more than 100 countries.

We are a leading supplier of medicines to the HIV/AIDS community, providing access to high quality and affordable antiretrovirals in over 100 countries. Approximately 40% of the 23.31 million people on treatment for HIV use our products.
In Australia we supported a major trial of pre-exposure prophylaxis medication for HIV/AIDS which led to its PBS reimbursement ensuring this valuable prevention therapy is affordable.
Our new state-of-the-art warehouse and distribution centre in Bundamba, Queensland stores extensive volumes of stock and a wide range of critical products under one roof. An order can be shipped from there to anywhere around the country overnight.
In Australia many of our employees are highly qualified in engineering, science and pharmacy. Of almost 600 employees at our Carole Park, Queensland manufacturing site, over 220 have a degree or higher qualification and over 25 have a trade qualification.